SEC Form 4 · accession 0001179110-16-026632
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean-Yves Pavee
Officer — Senior Vice President
Period of report
Jun 10, 2016
Accepted (ET)
Jun 17, 2016 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Jun 10, 2016 | G | 2,934 | $0.00 | D | 33,215 | D | |
| Common shares without par valueF2 | Jun 10, 2016 | G | 1,467 | $0.00 | A | 4,433 | I | By daughter |
| Common shares without par valueF3 | Jun 10, 2016 | G | 1,467 | $0.00 | A | 4,433 | I | By son |
| Common shares without par valueF1 | holding | — | — | — | 3,179 | I | Profit Sharing Trust | |
| Common shares without par valueF2 | holding | — | — | — | 2,967 | I | By daughter |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of June 14, 2016.
- F2The reporting person disclaims beneficial ownership of all securities held by his daughter.
- F3The reporting person disclaims beneficial ownership of all securities held by his son.